M A Conant, K M Opp, D Poretz, R G Mills. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » AIDS-Related Opportunistic Infections/complicationsAIDS-Related Opportunistic Infections/drug therapyAcquired Immunodeficiency Syndrome/complicationsAcquired Immunodeficiency Syndrome/drug therapyAnti-HIV Agents/therapeutic useDouble-Blind MethodHIV Protease Inhibitors/therapeutic useHumansMaleMiddle AgedRitonavir/therapeutic useSarcoma, Kaposi/complicationsSarcoma, Kaposi/drug therapyTreatment Outcome
Substances: See more » Anti-HIV AgentsHIV Protease InhibitorsRitonavir
Year: 1997 PMID: 9256954 DOI: 10.1097/00002030-199710001-00007
Source DB: PubMed Journal: AIDS ISSN: 0269-9370 Impact factor: 4.177